Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-08

Clinical Trial Update: A Study of SK-1405 in Hemodialysis Patients With Uremic Pruritus [Phase 2]

View source ↗

Summary

Phase 2 trial for SK-1405 in hemodialysis patients with uremic pruritus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SK-1405

Snippet

Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd. | Conditions: Uremic Pruritus in Hemodialysis Patients | Phase 2 | Status: COMPLETED